JP2012115277A5 - - Google Patents

Download PDF

Info

Publication number
JP2012115277A5
JP2012115277A5 JP2012020504A JP2012020504A JP2012115277A5 JP 2012115277 A5 JP2012115277 A5 JP 2012115277A5 JP 2012020504 A JP2012020504 A JP 2012020504A JP 2012020504 A JP2012020504 A JP 2012020504A JP 2012115277 A5 JP2012115277 A5 JP 2012115277A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
polypeptide according
yrkyrkryyyrkyrkryy
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012020504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012115277A (ja
Filing date
Publication date
Priority claimed from GBGB0329254.7A external-priority patent/GB0329254D0/en
Application filed filed Critical
Publication of JP2012115277A publication Critical patent/JP2012115277A/ja
Publication of JP2012115277A5 publication Critical patent/JP2012115277A5/ja
Pending legal-status Critical Current

Links

JP2012020504A 2003-12-17 2012-02-02 ウイルス感染の治療 Pending JP2012115277A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0329254.7 2003-12-17
GBGB0329254.7A GB0329254D0 (en) 2003-12-17 2003-12-17 Treatment of viral infections

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006544559A Division JP2007535910A (ja) 2003-12-17 2004-12-17 ウイルス感染の治療

Publications (2)

Publication Number Publication Date
JP2012115277A JP2012115277A (ja) 2012-06-21
JP2012115277A5 true JP2012115277A5 (US20090208454A1-20090820-C00047.png) 2013-06-27

Family

ID=30471239

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006544559A Pending JP2007535910A (ja) 2003-12-17 2004-12-17 ウイルス感染の治療
JP2012020504A Pending JP2012115277A (ja) 2003-12-17 2012-02-02 ウイルス感染の治療

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006544559A Pending JP2007535910A (ja) 2003-12-17 2004-12-17 ウイルス感染の治療

Country Status (11)

Country Link
US (3) US7691382B2 (US20090208454A1-20090820-C00047.png)
EP (2) EP1709075B9 (US20090208454A1-20090820-C00047.png)
JP (2) JP2007535910A (US20090208454A1-20090820-C00047.png)
CN (2) CN1894281B (US20090208454A1-20090820-C00047.png)
AU (1) AU2004299343B8 (US20090208454A1-20090820-C00047.png)
CA (1) CA2548585A1 (US20090208454A1-20090820-C00047.png)
DK (1) DK1709075T3 (US20090208454A1-20090820-C00047.png)
ES (1) ES2389078T3 (US20090208454A1-20090820-C00047.png)
GB (1) GB0329254D0 (US20090208454A1-20090820-C00047.png)
PL (1) PL1709075T3 (US20090208454A1-20090820-C00047.png)
WO (1) WO2005058959A2 (US20090208454A1-20090820-C00047.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) * 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
US8044179B2 (en) * 2005-09-13 2011-10-25 National Research Council Of Canada Methods and compositions for modulating tumor cell activity
PL2085774T3 (pl) * 2008-02-01 2018-08-31 Kraft Foods R & D, Inc. Sposób określania konsystencji materiału spożywczego
WO2009102715A2 (en) * 2008-02-11 2009-08-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Peptide therapy for ocular herpes infections
JP5553336B2 (ja) * 2008-02-14 2014-07-16 国立大学法人京都工芸繊維大学 ペプチド、当該ペプチドの用途及び生産方法並びに当該ペプチドが固定化された固相及びその生産方法
AU2010324506B2 (en) 2009-11-24 2015-02-26 Alethia Biotherapeutics Inc. Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
US20120053128A1 (en) * 2010-08-26 2012-03-01 Xavier University Method of inhibiting angiogenesis
US9234026B2 (en) 2011-07-21 2016-01-12 University of Pittsburgh—of the Commonwealth System of Higher Education Apolipoprotein E polypeptides and their use
US9822170B2 (en) 2012-02-22 2017-11-21 Alethia Biotherapeutics Inc. Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer
US9636299B2 (en) 2012-03-29 2017-05-02 Xavier University Of Louisiana Method for treating diabetic retinopathy
BR112017006575B1 (pt) * 2014-10-01 2023-11-21 Plant Health Care, Inc Peptídeo isolado, polipeptídeo de fusão, composição e métodos de conferir resistência à doença às plantas, de potencializar o crescimento da planta, de aumentar a tolerância da planta ao estresse biótico ou ao estresse abiótico e de modular a sinalização bioquímica da planta
WO2016054250A1 (en) * 2014-10-01 2016-04-07 Cascadia Life Sciences Llc Anti-viral peptides
CN107041140A (zh) 2014-10-01 2017-08-11 植物保健公司 具有破坏的过敏反应盒的激发子肽及其用途
CN108883148A (zh) 2016-04-06 2018-11-23 植物保健公司 过敏反应激发子来源的肽及其用途
WO2017176588A1 (en) 2016-04-06 2017-10-12 Plant Health Care, Inc. Beneficial microbes for delivery of effector peptides or proteins and use thereof
WO2020223581A1 (en) * 2019-04-30 2020-11-05 Maxwell Biosciences, Inc. Halogenated antimicrobial peptoids
CN116813712B (zh) * 2023-06-16 2024-03-29 东北农业大学 一种富含Trp的α-螺旋结构抗菌肽W33及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
JP2001518449A (ja) * 1997-09-30 2001-10-16 デューク・ユニバーシティー アポリポタンパク質e/成長因子複合体およびその使用法
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
GB0200757D0 (en) * 2002-01-15 2002-02-27 Univ Manchester Diagnostic methods
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections

Similar Documents

Publication Publication Date Title
JP2012115277A5 (US20090208454A1-20090820-C00047.png)
JP2012126742A5 (US20090208454A1-20090820-C00047.png)
JP2010166916A5 (US20090208454A1-20090820-C00047.png)
JP2012136541A5 (US20090208454A1-20090820-C00047.png)
JP2015517489A5 (US20090208454A1-20090820-C00047.png)
JP2015522576A5 (US20090208454A1-20090820-C00047.png)
JP2012176978A5 (US20090208454A1-20090820-C00047.png)
JP2011528896A5 (US20090208454A1-20090820-C00047.png)
JP2013520405A5 (US20090208454A1-20090820-C00047.png)
JP2011528901A5 (US20090208454A1-20090820-C00047.png)
JP2016534034A5 (US20090208454A1-20090820-C00047.png)
JP2010227101A5 (US20090208454A1-20090820-C00047.png)
JP2019533722A5 (US20090208454A1-20090820-C00047.png)
RU2015119517A (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
JP2012529293A5 (US20090208454A1-20090820-C00047.png)
JP2011528895A5 (US20090208454A1-20090820-C00047.png)
JP2017532343A5 (US20090208454A1-20090820-C00047.png)
JP2015514132A5 (US20090208454A1-20090820-C00047.png)
JP2007535910A5 (US20090208454A1-20090820-C00047.png)
JPWO2019156137A5 (US20090208454A1-20090820-C00047.png)
JP2010508030A5 (US20090208454A1-20090820-C00047.png)
JP2015533791A5 (US20090208454A1-20090820-C00047.png)
JP2011528897A5 (US20090208454A1-20090820-C00047.png)
JP2015513318A5 (US20090208454A1-20090820-C00047.png)
JP2015521206A5 (US20090208454A1-20090820-C00047.png)